miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple sclerosis disease

This study represents the first report of the miR-455-5p acts as an anti-inflammatory role in MS, at least partially through targeting MyD88 and REL. This study may provide imp ortant information for the use of miR-455-5p as a novel strategy to improve the severity of disease and control inflammation and attack in MS patients.
Source: Immunogenetics - Category: Genetics & Stem Cells Source Type: research